Morgan Stanley placed a target price of Rs 502 on Dr. Agarwal's Health Care stock, implying an upside potential of 17% to the previous close.

Morgan Stanley expects Dr. Agarwal's revenue and Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to ...

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...

In a remarkable acknowledgment of 'Nari Shakti' for International Women's Day, Prime Minister Modi's social media accounts were animated by Dr. Anjlee Agarwal, the visionary founder of SamarthaYam ...

Dr Naresh Trehan, Chairman Managing Director, Medanta Hospital, has addressed the rising concern about heart attacks in young ...

In this episode of Market Guru, Shailendra Bhatnagar takes a deep dive into the current market volatility and explores the ...

Chairing a review meeting on the progress of key government programmes, Mundian, accompanied by deputy commissioner Dr Himanshu Aggarwal, called upon the police and health departments to adopt a multi ...

On the occasion of International Women's Day, Dr Anjlee Agarwal, founder of Samarthyam, Centre for Universal Accessibility, ...

On World Kidney Day, Dr Munindra Kumar, Co-Founder of NEPHRUS (Chain of Kidney Care & Dialysis Centers), extends his wishes ...

Dr. Agarwals Eye Hospital, a renowned eyecare chain with a strong presence across India and abroad, has inaugurated its new ...

Oyo founder Ritesh Agarwal anticipates significant growth in India's religious tourism sector, predicting it could generate ...